"Fuel cell-based air independent propulsion (AIP) system of Naval Materials Research Laboratory (NMRL) for strategic applications (e.g. submarines) demand an on-board generation of hydrogen (H2) from diesel.On board generation of hydrogen through autothermal reforming of diesel looks attractive because of high volumetric energy density and easy availability of diesel.

This process is usually a catalytic process, but as the sulphur content in commercial diesel accelerates the reforming catalyst deactivation. The praysee and his team developed a non- catalytic autothermal reformer at IIT Gandhinagar, but the low single-pass efficiency of this reformer in spite of an efficient pre-reactor, developed along with it requires a larger reformer size and diesel recycling, thereby increasing the system complexity.The single-pass conversion efficiency of vaporized diesel fuel in a non-catalytic autothermal reformer can be enhanced with the help of an efficent static mixer (spiral or SiC foam). The project aims to enhance the performance of a non-catalytic diesel autothermal reformer using static mixtures to increase the submerged endurance of the submaries"

"Human urine exists in two states, fresh and hydrolyzed, which dictates the form of nitrogen able to be recovered. In fresh urine, the dominant form of nitrogen is urea. The urea can be hydrolyzed into ammonia and in this project, we aim to recover the ammonia that is present in free form as well as which has been obtained upon urea hydrolysis.

The project's goals are to (i) fabricate novel nanobio composites capable of urea hydrolysis and adsorption, (ii) use the adsorbed nitrogen as a potent source of ammonia, and (iii) development of an urine treatment system using our approach to hydrolysis and recovery of ammonia."

We propose to develop such a compliant actuator that will be of immediate utility in robotics applications and can be commercialized as made available as an indegenous product. Actuators and robots for precise movements along with the ability to manipulate objects in predictable situations and predictable environments have matured over the past several decades, and such robots with high degree of sophistication are widely used in industries and various applications.

These actuators and robots are stiff in interaction and have no compliance. However, it is being increasingly recognized that compliant actuators and with series-elastic elements offer several advantages over traditional actuators in terms of safety (due to its relatively low mechanical impedance), robustness, and increased peak power output. These are particularly useful for robots operating in uncertain environments. In addition, force bandwidth and ability to accommodate higher communication delays are other highly desirable features of SEA that make them attractive in many practical applications. Since robots are increasingly being developed for tasks involving physical interactions with uncertain environments, humans, or other robots, compliant actuation is desired in such situations. This area has been receiving much attention of late and is a fast-growing area in the domain of robotics.

Motor-based actuators are central elements in electromechanical devices. The vast majority of such devices also require precise control of motors (speed or velocity or torque) that necessitates the use of 'motor drivers' and micro-controllers. The current generation of motor drivers is not optimal.

Its implementation leads to motors' electrical noise (buzzing sounds), fluctuations in motor currents, poorer voltage resolution in motor control and less-efficient motor characteristics.We propose novel hardware & software with a new approach to constructing a motor driver. We aim to develop a device that improves all the shortcomings mentioned earlier.

We are working to create shared value among all the stakeholder in the value chain of round fruit handling and management. We are in the process to develop on field fruit Collection spiral arm equipment to collect round fruit easily and on field fruit portable gravity sorting equipment for round fruit. Also, supporting with packaging and linking to market and processing centre

We at Exposit Immersive Solution Private Limited are a group of young entrepreneurs supported by the Government of Gujarat which serves the industries with stunning Augmented and Virtual Reality innovative solutions to help enterprises in their Employees training and productivity, Marketing, Educational Experiences, Awareness Immersive Campaign and attentive Customer outreach.

Exposit is an Award-winning and Gold Medal Startup honored by Hon. Home Minister of India Shri Amit Shah. We served Industrial Clients including Adani Group, Government of Gujarat, Pal-V (the Netherlands based Flying Car Company) and Many More.

Product/Service: Ride services platform for shared, low-cost, and cashless travel in cities Developing a mobility architecture and platform, including a tech stack and IoT hardware, for enabling shared rides for the last-mile with high passenger throughput. We have formulated a node-network based transit model that allows real-time demand-responsive route-based shared rides to be operated very efficiently.

In order to bring efficiency to shared rides with high passenger volume, we are developing a user touchpoint hardware (for use in the outdoor city environment), which serves as a smart pick-up/drop-off location for services active in the mobility platform. Our novel transit-enabling hardware has multiple functions: enabling cashless access to transit services; active localization of fleet vehicles; passenger and vehicle throughput management using sensor data; monitoring the environmental state of the device and its vicinity. We reduce usage barriers by providing services in regional languages, and by enabling multimodal cashless payments to cater to non-smartphone users in the Bharat segment. Our novel kiosk hardware leverages AR-based UI/UX to simplify how users access services, removing language, knowledge, and economic barriers.

We envision to create an engineering based digital twin for the manufacturing Industry. We have selected Investment casting industry as our target industry. We will invent devices to measure the properties of various properties such as permeabiliy, specific gravity etc. Technology such as Internet of Things, Artificial Intelligence, and intelligent feedback system will be utilized to improve the standardization, improve the overall quality, and increase the efficiency. Currently we have inevented two devices which measures permeability of shell and viscosity of ceramic slurry.

Concrete printing is rapidly emerging and disruptive technology in construction sector. However, automated reinforcement of concrete printing is still challenging which renders the technology to harness its full potential. Fibre mesh reinforcement seems a plausible approach for reinforcement. The current project aims to design and develop an indigenous concrete printing setup for synchronous introduction of fibre mesh in concrete layers (filaments) during the printing process itself.

A innovative design of nozzle (printhead) will be developed for automatic embedment of fibre mesh in concrete layers. Such printed layers are expected to exhibit the properties somewhat similar to textile reinforced concrete (TRC). Additionally, it has several other technical advantages also.

We build smart solutions for cooling energy optimisation by leveraging AI & IoT for residential and commercial spaces, lowering carbon footprint for a better future.

Our idea is to develop indigenous anti-drone technology to prevent the accidents/tragedies caused by intruder drones at sensitive areas such as airports, public gatherings, borders of countries, the oil and gas industry, and other critical locations. We propose to capture the intruder drone in a net that is carried by multiple hunter drones. The hunter drones are equipped with advanced AI algorithms to automatically detect, chase and seize the intruder drone.

Development of miniaturised diagnostic and other sensing solution based on plasmonic nanoparticles conjugated to fibre optic microfluidic lab-on-a-chip architecture and coupled to smartphone for analysis and readout.

We are developing small organic fluorescent molecules for targeted organelle imaging to enhance the understanding of cellular function. At Koshika Bio, we have designed a library of these probes to be cost-effective, easy to synthesize, and highly specific for visualizing organelles within living cells. Our goal is to establish this library as a leading platform for organelle imaging, contributing to advancements in cell biology, drug discovery, and disease diagnosis.

Conventionally available cancer therapy for example chemotherapy lacks precision and causes toxicity problems. Therefore, targeted drug delivery is preferred as an alternative method to reduce side effects and improve drug bioavailability. But there are problems of drug leakage before reaching the site. Hence CQDs (carbon quantum dots) are proposed to be efficient targeting agents with dual nano carriers properties of bioimaging and targeted drug delivery with minimum cytotoxicity.

Introducing a new drug candidate to the market is a complex and time-demanding process that at least costs pharmaceuticals an average of billion dollars and 10-15 years of research and development. Out of the four stages of drug discovery, the critical yet time-consuming process is identifying the hit and valid drug candidate for the target of interest. This process covers at least 5-6 years in the overall phase of drug discovery. Hence, reducing this gap would eventually decrease the time gap in identifying the hit molecules and fast-track the drug discovery process.

Our previous findings with TTK, a protein kinase that is highly overexpressed in breast cancer, we aim to develop the protein kinase assay to screen our in-house designed small molecule as a TTK inhibitor. The project goals are to i) design and develop the protein expression and purification assay for TTK and ii) develop a protein inhibition assay for screening the small molecules. The project will further be taken up to more proteins to design the assay kit.

Skin is the largest organ of any living species and plays an essential role in protecting internal organs against external damage and microbial invasion. Civilian settings and battlefields can cause serious skin injuries. Recent data indicate every year roughly 2 million people die due to hemorrhaging or blood loss and physical trauma. Dead due to bleeding is very quick and requires QUICK control.

We are addressing this issue by modifying blood properties using suitable biopolymers. Example, traumatic injury for soldiers in combat, civilians involved in serious accidents, violent altercations, and uncontrolled hemorrhage during childbirth or to pregnant women. Similar list of unmet needs is also available from veterinary areas where rapid and reliable solutions are needed for domestic animals. Some non-health care problems, like blood leakage proof feminine hygiene pads and control of hospital acquired infection due to blood spillage in hospitals, also need similar solutions.

We are working on an electric trike vehicle project. We think that most two wheelers in the world are not safe enough for the riders. We want to make them safer by adding new features and design changes. One of our innovations is the trike system, which improves the stability, braking and handling of the vehicle. This system can help the rider avoid accidents and feel more confident.

We have chosen to use an electric scooter as our base model, because it is also good for the environment and reduces pollution.

Aspiel strives to innovate,test and introduce newer devices for parenteral drug delivery. Parenteral drug is a very important route for drug delivery which has its own set of complications and adverse effects. The conventional devices available in the market have been accepted for decades; however along with these devices, the complications associated with their use have also steadily shown their presence in the medical field.

Aspiel's team has identified these limitations of certain devices and are leading development of newer devices to overcome these challenges. They are currently in the prototype development phase and expect to validate the device over the next 1 year.

The present invention provides smart generation of biocompatible Analgesic Antimicrobial Haemostatic and wound healing technology useful in facilitating and maintaining hemostasis and promoting wound healing.

The main objective of this innovation is to provide Analgesic Antimicrobial hemostatic and wound healing preparation gel, Spongy and powder composition and support highly Broad-spectrum antimicrobial effects against more than 600 Gram positive and gram-negative pathogen including Bacteria, Fungi, Virus. This product is bio degradable and provides Novel Analgesic hemostatic and wound healing gel, Spongy and powder to Surgical and traumatic dressing based on biological active material that can prevent microbial infections, induce gel, the hemostasis action and stop bleeding within 30 Sec to 2 Min with help of mild pressure work as sealant for organ.

At Kapidhwaj AI, we're working on a modest yet impactful shift in security and surveillance. While traditional CCTV systems do well with cause detection, we believe the future calls for real-time event detection and immediate response. Our platform aims to blend AI, the Internet of Things, and Cloud Computing to improve upon the limitations of existing systems.

Through our Nidhi Prayas-backed efforts, we are developing a prototype that integrates various surveillance edge devices and offers some neat features, like cloud integration, real-time event detection and user-friendly notifications. It's our small step towards making surveillance more proactive and effective.

We specialize in developing monoclonal antibodies targeting hepatitis B and are creating highly sensitive immunological assays. Our expertise in hybridoma technology enables us to produce indigenous Antibody, serving as a valuable import substitute for manufacturers involved in HBV detection kits.

With a well-established lab, we address the challenges faced by India, falling within intermediate hepatitis B endemicity, by offering precise diagnostic screening tests crucial for individual and population screening. Recognizing the scarcity of indigenous raw materials, we propose the establishment of reagents and assays to contribute to the manufacture of HBV diagnostic kits, supporting the fight against this fatal infection.

We are in the waste-to-renewable-energy generation (fuel and burner) business. We produce solid fuel pellets from municipal solid waste and agricultural waste which can be cleanly combusted in our Industrial grade fully automatic burners. These pellets are a replacement for Industrial fossil fuels (coal, oil, and natural gas) that are harmful to the environment. This solid fuel is carbon neutral, self-sustaining, locally sourced and an import substitution.

We manufacture industrial solid fuel burners that replace fossil fuel-fired burners in industrial process heating. Boilers, thermic fluid heaters, hot air generators, furnaces, kilns, and ovens can be retrofitted with our burners and start their decarbonisation journey using our RDF pellets. We have been deploying our solutions in Industries since Dec 2021.

I am currently developing Saral Airway (Single use Assured and Reliable Around Laryngeal Airway), a rescue airway device for emergency situations that can be used through the nasal route. Unlike existing devices, Saral Airway is specifically designed for patients with restricted oral cavities due to trauma, tumors, or limited mouth opening.

Additionally, it can be used in normal patients via both oral and nasal routes. This indigenously developed airway is cost-effective, available in all sizes from neonates to adults, and features an easy insertion technique suitable even for laypersons. Being disposable, it prevents infection transmission and ensures a 100% success rate in securing an airway. As a Medtech Innovator, I focus on creating innovative solutions to improve airway management in emergencies. This project merges my medical expertise with cutting-edge technology to enhance patient care and safety.

Ares Systems is developing novel high-efficiency electrolyser systems for onsite hydrogen generation. Our membraneless technology is high efficiency (>90%), low capex (<200$/kW), and fully indigenously developed.

We are aspiring to develop a modern way of extracting essential oils vital to humans. In doing so we want to make our methods as energy efficient as possible. We have developed a much cheaper and much less energy consuming method to produce essential oils vital to us. We aim to reduce the cost of essential oils and hence reduce the cost of pharmaceuticals and cosmetics.

Pravah Engineering is a startup focused on developing indigenous electric mobility solutions targeting unique problems specifically in the Indian market for mass adoption of electric vehicles. Our mission is to contribute to the growing Indian automotive industry with innovative solutions for the ongoing EV revolution.

We are currently developing a patented transmission system for heavy duty electric tractors(40-100HP). It uses 2 Continuously Variable Transmission controlled by electric linear actuators, paired with a constant speed AC electric motor. This ensures excellent slow speed high torque performance in off-road and agricultural use cases while keeping the cost of the electric tractor competitive to traditional diesel alternatives. We have recently received the grant for our patent, and we plan to license and market it to existing OEMs(Original Equipment Manufacturers).

Our institute provides diagnostic services for the animals. We also provide gross and histopathology consultancy services for pre-clinical toxicity/efficacy studies on Rodents and non-rodents as per the ICH, OECD, and GLP guidelines. The statistically analyzed and interpreted reports will be made available as per the formats of regulatory as well as academic submissions.

High-quality digital images of the gross and microscopic findings will be provided. Diagnostic histopathology reports for individual large/pet animal tissue samples will also be provided.